Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to several observations, agitation prevalence ranges from 30 to 50% in Alzheimer's disease, 30% in dementia with Lewy bodies, 40% in f...

Full description

Bibliographic Details
Main Authors: Claudia Carrarini, Mirella Russo, Fedele Dono, Filomena Barbone, Marianna G. Rispoli, Laura Ferri, Martina Di Pietro, Anna Digiovanni, Paola Ajdinaj, Rino Speranza, Alberto Granzotto, Valerio Frazzini, Astrid Thomas, Andrea Pilotto, Alessandro Padovani, Marco Onofrj, Stefano L. Sensi, Laura Bonanni
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.644317/full
id doaj-fb90d056a6254933b97f40c65826deb4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Claudia Carrarini
Mirella Russo
Fedele Dono
Filomena Barbone
Marianna G. Rispoli
Laura Ferri
Martina Di Pietro
Anna Digiovanni
Paola Ajdinaj
Rino Speranza
Alberto Granzotto
Alberto Granzotto
Alberto Granzotto
Valerio Frazzini
Valerio Frazzini
Valerio Frazzini
Astrid Thomas
Andrea Pilotto
Andrea Pilotto
Alessandro Padovani
Marco Onofrj
Marco Onofrj
Stefano L. Sensi
Stefano L. Sensi
Laura Bonanni
Laura Bonanni
spellingShingle Claudia Carrarini
Mirella Russo
Fedele Dono
Filomena Barbone
Marianna G. Rispoli
Laura Ferri
Martina Di Pietro
Anna Digiovanni
Paola Ajdinaj
Rino Speranza
Alberto Granzotto
Alberto Granzotto
Alberto Granzotto
Valerio Frazzini
Valerio Frazzini
Valerio Frazzini
Astrid Thomas
Andrea Pilotto
Andrea Pilotto
Alessandro Padovani
Marco Onofrj
Marco Onofrj
Stefano L. Sensi
Stefano L. Sensi
Laura Bonanni
Laura Bonanni
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
Frontiers in Neurology
agitation
dementia
hyperkinetic delirium
Alzheimer's Disease
Dementia with Lewy Bodies
Frontotemporal Dementia
author_facet Claudia Carrarini
Mirella Russo
Fedele Dono
Filomena Barbone
Marianna G. Rispoli
Laura Ferri
Martina Di Pietro
Anna Digiovanni
Paola Ajdinaj
Rino Speranza
Alberto Granzotto
Alberto Granzotto
Alberto Granzotto
Valerio Frazzini
Valerio Frazzini
Valerio Frazzini
Astrid Thomas
Andrea Pilotto
Andrea Pilotto
Alessandro Padovani
Marco Onofrj
Marco Onofrj
Stefano L. Sensi
Stefano L. Sensi
Laura Bonanni
Laura Bonanni
author_sort Claudia Carrarini
title Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_short Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_full Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_fullStr Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_full_unstemmed Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
title_sort agitation and dementia: prevention and treatment strategies in acute and chronic conditions
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-04-01
description Agitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to several observations, agitation prevalence ranges from 30 to 50% in Alzheimer's disease, 30% in dementia with Lewy bodies, 40% in frontotemporal dementia, and 40% in vascular dementia (VaD). With an overall prevalence of about 30%, agitation is the third most common neuropsychiatric symptoms (NPS) in dementia, after apathy and depression, and it is even more frequent (80%) in residents of nursing homes. The pathophysiological mechanism underlying agitation is represented by a frontal lobe dysfunction, mostly involving the anterior cingulate cortex (ACC) and the orbitofrontal cortex (OFC), respectively, meaningful in selecting the salient stimuli and subsequent decision-making and behavioral reactions. Furthermore, increased sensitivity to noradrenergic signaling has been observed, possibly due to a frontal lobe up-regulation of adrenergic receptors, as a reaction to the depletion of noradrenergic neurons within the locus coeruleus (LC). Indeed, LC neurons mainly project toward the OFC and ACC. These observations may explain the abnormal reactivity to weak stimuli and the global arousal found in many patients who have dementia. Furthermore, agitation can be precipitated by several factors, e.g., the sunset or low lighted environments as in the sundown syndrome, hospitalization, the admission to nursing residencies, or changes in pharmacological regimens. In recent days, the global pandemic has increased agitation incidence among dementia patients and generated higher distress levels in patients and caregivers. Hence, given the increasing presence of this condition and its related burden on society and the health system, the present point of view aims at providing an extensive guide to facilitate the identification, prevention, and management of acute and chronic agitation in dementia patients.
topic agitation
dementia
hyperkinetic delirium
Alzheimer's Disease
Dementia with Lewy Bodies
Frontotemporal Dementia
url https://www.frontiersin.org/articles/10.3389/fneur.2021.644317/full
work_keys_str_mv AT claudiacarrarini agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT mirellarusso agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT fedeledono agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT filomenabarbone agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT mariannagrispoli agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT lauraferri agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT martinadipietro agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT annadigiovanni agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT paolaajdinaj agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT rinosperanza agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT albertogranzotto agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT albertogranzotto agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT albertogranzotto agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT valeriofrazzini agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT valeriofrazzini agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT valeriofrazzini agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT astridthomas agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT andreapilotto agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT andreapilotto agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT alessandropadovani agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT marcoonofrj agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT marcoonofrj agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT stefanolsensi agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT stefanolsensi agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT laurabonanni agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
AT laurabonanni agitationanddementiapreventionandtreatmentstrategiesinacuteandchronicconditions
_version_ 1721525546235461632
spelling doaj-fb90d056a6254933b97f40c65826deb42021-04-16T04:58:45ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-04-011210.3389/fneur.2021.644317644317Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic ConditionsClaudia Carrarini0Mirella Russo1Fedele Dono2Filomena Barbone3Marianna G. Rispoli4Laura Ferri5Martina Di Pietro6Anna Digiovanni7Paola Ajdinaj8Rino Speranza9Alberto Granzotto10Alberto Granzotto11Alberto Granzotto12Valerio Frazzini13Valerio Frazzini14Valerio Frazzini15Astrid Thomas16Andrea Pilotto17Andrea Pilotto18Alessandro Padovani19Marco Onofrj20Marco Onofrj21Stefano L. Sensi22Stefano L. Sensi23Laura Bonanni24Laura Bonanni25Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyBehavioral Neurology and Molecular Neurology Units, Center for Advanced Studies and Technology–CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyInstitute for Mind Impairments and Neurological Disorders–iMIND, University of California, Irvine, Irvine, CA, United StatesBehavioral Neurology and Molecular Neurology Units, Center for Advanced Studies and Technology–CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyInstitut du Cerveau et de la Moelle épinière, ICM, INSERM UMRS 1127, CNRS UMR 7225, Pitié Salpêtrière Hospital, Paris, FranceAP-HP, GH Pitie-Salpêtrière-Charles Foix, Epilepsy Unit and Neurophysiology Department, Paris, FranceDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyParkinson's Disease Rehabilitation Centre, FERB ONLUS–S. Isidoro Hospital, Trescore Balneario, ItalyNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyBehavioral Neurology and Molecular Neurology Units, Center for Advanced Studies and Technology–CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyBehavioral Neurology and Molecular Neurology Units, Center for Advanced Studies and Technology–CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyBehavioral Neurology and Molecular Neurology Units, Center for Advanced Studies and Technology–CAST, University G. d'Annunzio of Chieti-Pescara, Chieti, ItalyAgitation is a behavioral syndrome characterized by increased, often undirected, motor activity, restlessness, aggressiveness, and emotional distress. According to several observations, agitation prevalence ranges from 30 to 50% in Alzheimer's disease, 30% in dementia with Lewy bodies, 40% in frontotemporal dementia, and 40% in vascular dementia (VaD). With an overall prevalence of about 30%, agitation is the third most common neuropsychiatric symptoms (NPS) in dementia, after apathy and depression, and it is even more frequent (80%) in residents of nursing homes. The pathophysiological mechanism underlying agitation is represented by a frontal lobe dysfunction, mostly involving the anterior cingulate cortex (ACC) and the orbitofrontal cortex (OFC), respectively, meaningful in selecting the salient stimuli and subsequent decision-making and behavioral reactions. Furthermore, increased sensitivity to noradrenergic signaling has been observed, possibly due to a frontal lobe up-regulation of adrenergic receptors, as a reaction to the depletion of noradrenergic neurons within the locus coeruleus (LC). Indeed, LC neurons mainly project toward the OFC and ACC. These observations may explain the abnormal reactivity to weak stimuli and the global arousal found in many patients who have dementia. Furthermore, agitation can be precipitated by several factors, e.g., the sunset or low lighted environments as in the sundown syndrome, hospitalization, the admission to nursing residencies, or changes in pharmacological regimens. In recent days, the global pandemic has increased agitation incidence among dementia patients and generated higher distress levels in patients and caregivers. Hence, given the increasing presence of this condition and its related burden on society and the health system, the present point of view aims at providing an extensive guide to facilitate the identification, prevention, and management of acute and chronic agitation in dementia patients.https://www.frontiersin.org/articles/10.3389/fneur.2021.644317/fullagitationdementiahyperkinetic deliriumAlzheimer's DiseaseDementia with Lewy BodiesFrontotemporal Dementia